Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corebridge Financial (CRBG) Asset Writedowns and Impairment (2022 - 2025)

Historic Asset Writedowns and Impairment for Corebridge Financial (CRBG) over the last 4 years, with Q3 2025 value amounting to $12.0 million.

  • Corebridge Financial's Asset Writedowns and Impairment rose 7142.86% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.0 million, marking a year-over-year decrease of 4519.23%. This contributed to the annual value of $69.0 million for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Corebridge Financial's Asset Writedowns and Impairment is $12.0 million, which was up 7142.86% from $11.0 million recorded in Q2 2025.
  • Corebridge Financial's 5-year Asset Writedowns and Impairment high stood at $49.0 million for Q4 2023, and its period low was $7.0 million during Q3 2024.
  • Moreover, its 4-year median value for Asset Writedowns and Impairment was $17.0 million (2022), whereas its average is $19.5 million.
  • In the last 5 years, Corebridge Financial's Asset Writedowns and Impairment soared by 25000.0% in 2023 and then plummeted by 7142.86% in 2024.
  • Quarter analysis of 4 years shows Corebridge Financial's Asset Writedowns and Impairment stood at $14.0 million in 2022, then soared by 250.0% to $49.0 million in 2023, then crashed by 71.43% to $14.0 million in 2024, then decreased by 14.29% to $12.0 million in 2025.
  • Its Asset Writedowns and Impairment was $12.0 million in Q3 2025, compared to $11.0 million in Q2 2025 and $20.0 million in Q1 2025.